NASDAQ: AVDLAvadel Pharmaceuticals PLC Stock Ownership - Who owns Avadel Pharmaceuticals?
Insider buying vs selling
Have Avadel Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Linda Palczuk | Director | 2025-01-21 | 5,000 | $7.93 | $39.64kBuy |
| Peter J. Thornton | Director | 2025-01-13 | 10,000 | $8.05 | $80.45kBuy |
| Eric J. Ende | Director | 2025-01-13 | 30,000 | $7.84 | $235.23kBuy |
| Thomas S. McHugh | Chief Financial Officer | 2024-12-13 | 2,300 | $10.44 | $24.02kBuy |
| Thomas S. McHugh | Chief Financial Officer | 2024-12-11 | 5,000 | $10.49 | $52.43kBuy |
| Geoffrey Michael Glass | Director | 2024-12-10 | 10,204 | $9.80 | $100.00kBuy |
| Geoffrey Michael Glass | Director | 2024-12-10 | 10,075 | $9.89 | $99.64kBuy |
| Gregory J. Divis | Chief Executive Officer | 2024-12-09 | 402 | $9.82 | $3.95kBuy |
| Gregory J. Divis | Chief Executive Officer | 2024-12-06 | 9,598 | $9.98 | $95.76kBuy |
| Linda Palczuk | Director | 2024-12-06 | 3,000 | $10.19 | $30.57kBuy |
AVDL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVDL insiders and whales buy or sell their stock.
AVDL Shareholders
What type of owners hold Avadel Pharmaceuticals PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Janus Henderson Group PLC | 11.46% | 11,132,131 | $210.29M | Institution |
| Blackrock Inc | 7.01% | 6,803,399 | $128.52M | Institution |
| Brandes Investment Partners LP | 6.68% | 6,487,642 | $122.55M | Institution |
| Two Seas Capital LP | 6.34% | 6,155,074 | $116.27M | Institution |
| Vanguard Group Inc | 5.73% | 5,564,259 | $105.11M | Institution |
| Gendell Jeffrey L | 5.33% | 5,176,611 | $97.79M | Institution |
| Broadfin Healthcare Master Fund Ltd | 4.26% | 4,133,464 | $78.08M | Insider |
| Polar Capital Holdings PLC | 4.12% | 3,999,338 | $75.55M | Institution |
| James E. Flynn | 3.78% | 3,674,506 | $69.41M | Insider |
| Kevin Kotler | 3.22% | 3,130,573 | $59.14M | Insider |
AVDL vs Pharmaceutical Stocks
Avadel Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.